HSG Holding’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.4K Hold
21,212
﹤0.01% 20
2025
Q4
$871K Hold
21,212
0.05% 18
2025
Q3
$215K Hold
21,212
0.01% 18
2025
Q2
$67K Hold
21,212
﹤0.01% 19
2025
Q1
$62.4K Hold
21,212
﹤0.01% 17
2024
Q4
$155K Hold
21,212
0.01% 18
2024
Q3
$64.5K Hold
21,212
﹤0.01% 18
2024
Q2
$135K Hold
21,212
0.01% 17
2024
Q1
$182K Hold
21,212
0.02% 18
2023
Q4
$206K Hold
21,212
0.02% 19
2023
Q3
$206K Hold
21,212
0.02% 20
2023
Q2
$456K Hold
21,212
0.05% 20
2023
Q1
$596K Hold
21,212
0.06% 19
2022
Q4
$477K Hold
21,212
0.05% 19
2022
Q3
$507K Hold
21,212
0.05% 20
2022
Q2
$617K Hold
21,212
0.06% 21
2022
Q1
$1.97M Hold
21,212
0.25% 18
2021
Q4
$2.02M Hold
21,212
0.18% 18
2021
Q3
$3.79M Hold
21,212
0.34% 16
2021
Q2
$6.25M Hold
21,212
0.44% 12
2021
Q1
$5.71M Hold
21,212
0.42% 10
2020
Q4
$4.9M Hold
21,212
0.41% 10
2020
Q3
$5.32M Hold
21,212
0.78% 10
2020
Q2
$5.73M Buy
+21,212
New +$5.81M 1.02% 9

Other funds holding BNR

HSG Holding's BNR Position: Q1 2026 in Review

HSG Holding held its Burning Rock Biotech (BNR) position steady in Q1 2026 at 21,212 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #20.

HSG Holding first reported a position in BNR in Q2 2020 and has held it in 24 quarters since. The position peaked at $6.25M in Q2 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • HSG Holding held 21,212 shares of Burning Rock Biotech worth $62.4K as of Q1 2026.
  • HSG Holding left its Burning Rock Biotech share count unchanged in Q1 2026.
  • Burning Rock Biotech made up ﹤0.01% of HSG Holding's portfolio in Q1 2026, its #20 holding.
  • HSG Holding first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 24 quarters since.
  • HSG Holding's Burning Rock Biotech position peaked at $6.25M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on HSG Holding's 13F filing for Q1 2026, filed 15 May 2026.